Mary S. Newman

2.7k total citations
21 papers, 2.1k citations indexed

About

Mary S. Newman is a scholar working on Molecular Biology, Biomaterials and Pathology and Forensic Medicine. According to data from OpenAlex, Mary S. Newman has authored 21 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Biomaterials and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Mary S. Newman's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (6 papers) and Lipid Membrane Structure and Behavior (6 papers). Mary S. Newman is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (6 papers) and Lipid Membrane Structure and Behavior (6 papers). Mary S. Newman collaborates with scholars based in United States, Portugal and United Kingdom. Mary S. Newman's co-authors include Martin C. Woodle, Peter K. Working, Charles Engbers, Michael Amantea, Paul S. Uster, Theresa M. Allen, Samuel Zalipsky, Francisco J. Plaza Martín, Gail Colbern and Zheng Zhu and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mary S. Newman

21 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary S. Newman United States	18	1.1k	972	343	282	246	21	2.1k
Arcadio Chonn Canada	19	2.2k 2.0×	1.4k 1.5×	490 1.4×	188 0.7×	257 1.0×	23	3.5k
Gustavo Helguera United States	25	1.4k 1.2×	711 0.7×	518 1.5×	139 0.5×	415 1.7×	45	2.8k
Marcel H.A.M. Fens Netherlands	28	1.7k 1.5×	1.0k 1.1×	720 2.1×	191 0.7×	268 1.1×	69	3.3k
Susan Wang United States	18	1.1k 1.0×	409 0.4×	316 0.9×	93 0.3×	228 0.9×	26	2.5k
Uma Prabhakar United States	22	1.2k 1.1×	748 0.8×	810 2.4×	302 1.1×	645 2.6×	41	3.1k
Beth Goins United States	37	1.4k 1.2×	1.4k 1.4×	1.0k 3.0×	214 0.8×	278 1.1×	107	3.6k
Rivka Cohen Israel	22	1.8k 1.6×	1.9k 1.9×	898 2.6×	114 0.4×	498 2.0×	36	3.6k
Jerome Connor United States	27	1.6k 1.4×	415 0.4×	237 0.7×	557 2.0×	138 0.6×	48	3.1k
Jihong Sun China	30	1.3k 1.2×	902 0.9×	1.3k 3.8×	140 0.5×	425 1.7×	129	3.6k
Tracy R. Daniels‐Wells United States	26	1.5k 1.3×	644 0.7×	454 1.3×	127 0.5×	553 2.2×	51	3.0k

Countries citing papers authored by Mary S. Newman

Since Specialization

Citations

This map shows the geographic impact of Mary S. Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary S. Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary S. Newman more than expected).

Fields of papers citing papers by Mary S. Newman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary S. Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary S. Newman. The network helps show where Mary S. Newman may publish in the future.

Co-authorship network of co-authors of Mary S. Newman

This figure shows the co-authorship network connecting the top 25 collaborators of Mary S. Newman. A scholar is included among the top collaborators of Mary S. Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary S. Newman. Mary S. Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Woodle, Martin C. & Mary S. Newman. (2018). Biological Properties of Sterically Stabilized Liposomes. 123–138. 1 indexed citations

Semba, Charles P., Dennis Swearingen, Valerie Smith, et al.. (2010). Safety and Pharmacokinetics of a Novel Lymphocyte Function-associated Antigen-1 Antagonist Ophthalmic Solution (SAR 1118) in Healthy Adults. Journal of Ocular Pharmacology and Therapeutics. 27(1). 99–104. 27 indexed citations

Harmatz, Paul, Roberto Giugliani, Ida Vanessa Döederlein Schwartz, et al.. (2006). Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. The Journal of Pediatrics. 148(4). 533–539.e6. 285 indexed citations

Amantea, Michael, Raleigh A. Bowden, Alan Forrest, et al.. (1999). The Population Pharmacokinetics of Amphotericin B Colloidal Dispersion in Patients Receiving Bone Marrow Transplants. Chemotherapy. 45(Suppl. 1). 48–53. 7 indexed citations

Newman, Mary S., Gail Colbern, Peter K. Working, Charles Engbers, & Michael Amantea. (1999). Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemotherapy and Pharmacology. 43(1). 1–7. 239 indexed citations

Yu, Rosie Z., Richard S. Geary, Janet M. Leeds, et al.. (1999). Pharmacokinetics and Tissue Disposition in Monkeys of an Antisense Oligonucleotide Inhibitor of Ha-Ras Encapsulated in Stealth Liposomes. Pharmaceutical Research. 16(8). 1309–1315. 35 indexed citations

Amantea, Michael, Mary S. Newman, Timothy M. Sullivan, Alan Forrest, & Peter K. Working. (1999). Relationship of dose intensity to the induction of palmar-plantar erythrodysesthia by pegylated liposomal doxorubicin in dogs. Human & Experimental Toxicology. 18(1). 17–26. 54 indexed citations

Working, Peter K., Mary S. Newman, Timothy M. Sullivan, & John T. Yarrington. (1999). Reduction of the Cardiotoxicity of Doxorubicin in Rabbits and Dogs by Encapsulation in Long-Circulating, Pegylated Liposomes. Journal of Pharmacology and Experimental Therapeutics. 289(2). 1128–1133. 99 indexed citations

Working, Peter K., Mary S. Newman, Timothy Sullivan, et al.. (1998). Comparative Intravenous Toxicity of Cisplatin Solution and Cisplatin Encapsulated in Long-Circulating, Pegylated Liposomes in Cynomolgus Monkeys. Toxicological Sciences. 46(1). 155–165. 27 indexed citations

10.

Harding, Jennifer, Charles Engbers, Mary S. Newman, Neil I. Goldstein, & Samuel Zalipsky. (1997). Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1327(2). 181–192. 154 indexed citations

11.

Slepushkin, Vladimir, Sérgio Simões, Paul Dazin, et al.. (1997). Sterically Stabilized pH-sensitive Liposomes, INTRACELLULAR DELIVERY OF AQUEOUS CONTENTS AND PROLONGED CIRCULATION IN VIVO. Journal of Biological Chemistry. 272(4). 2382–2388. 188 indexed citations

12.

Uster, Paul S., et al.. (1996). Insertion of poly(ethylene glycol) derivatized phospholipid into pre‐formed liposomes results in prolonged in vivo circulation time. FEBS Letters. 386(2-3). 243–246. 249 indexed citations

13.

Newman, Mary S., Michael Amantea, Timothy M. Sullivan, Alan Forrest, & Peter K. Working. (1996). PK/PD of pegylated-liposomal doxorubicin (LD) and the appearance of dermal lesions in dogs.. Clinical Pharmacology & Therapeutics. 59(2). 153–153. 1 indexed citations

14.

Allen, Theresa M., Mary S. Newman, Martin C. Woodle, E. Mayhew, & Paul S. Uster. (1995). Pharmacokinetics and anti‐tumor activity of vincristine encapsulated in sterically stabilized liposomes. International Journal of Cancer. 62(2). 199–204. 63 indexed citations

15.

Amantea, Michael, Raleigh A. Bowden, Alan Forrest, et al.. (1995). Population pharmacokinetics and renal function-sparing effects of amphotericin B colloidal dispersion in patients receiving bone marrow transplants. Antimicrobial Agents and Chemotherapy. 39(9). 2042–2047. 29 indexed citations

16.

Woodle, Martin C., Mary S. Newman, & Joel A. Cohen. (1994). Sterically Stabilized Liposomes: Physical and Biological Properties. Journal of drug targeting. 2(5). 397–403. 93 indexed citations

17.

Working, Peter K., Mary S. Newman, S.K. Huang, et al.. (1994). Pharmacokinetics, Biodistribution and Therapeutic Efficacy of Doxorubicin Encapsulated in Stealth® Liposomes (Doxil®). Journal of Liposome Research. 4(1). 667–687. 134 indexed citations

18.

Zalipsky, Samuel, et al.. (1994). Long circulating, cationic liposomes containing amino‐PEG‐phosphatidylethanolamine. FEBS Letters. 353(1). 71–74. 89 indexed citations

19.

Woodle, Martin C., Katherine K. Matthay, Mary S. Newman, et al.. (1992). Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1105(2). 193–200. 201 indexed citations

20.

Woodle, Martin C., Gert Storm, Mary S. Newman, et al.. (1992). Prolonged Systemic Delivery of Peptide Drugs by Long-Circulating Liposomes: Illustration with Vasopressin in the Brattleboro Rat. Pharmaceutical Research. 9(2). 260–265. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact